An update on biomarkers in axial spondyloarthritis
- 1 June 2016
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 15 (6) , 501-509
Abstract
No abstract availableKeywords
Funding Information
- MHCR (023728)
This publication has 130 references indexed in Scilit:
- ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitorsAnnals of the Rheumatic Diseases, 2011
- Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibilityNature Genetics, 2011
- No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitisClinical Rheumatology, 2011
- Elucidating the chromosome 9 association with AS; CARD9 is a candidate geneGenes & Immunity, 2010
- Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitisAnnals of the Rheumatic Diseases, 2009
- Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximabAnnals of the Rheumatic Diseases, 2008
- Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variantsNature Genetics, 2007
- Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibitionCellular Signalling, 2007
- Body composition, insulin, and leptin levels in patients with ankylosing spondylitisClinical Rheumatology, 2007
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984